AMH and ovarian hyperstimulation syndrome: We observed that AMH levels in our PCOMhyper-responders (based on a triggering day oestradiol of>3500 pg/dl, and/or >15 retrieved oocytes, and/or clinical manifestations of OHSS) were significantly higher thanin the PCOM suboptimal/normal responder group.